Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
AAM Launches Further Broadside At Proposed Blocking Act
Proposed Act ‘Well-Intended But Misguided,’ AAM Claims
Dec 15 2020
•
By
Dean Rudge
Weakening the 180-day exclusivity incentive will delay patient access, the AAM insists • Source: Shutterstock
More from Policy & Regulation
More from Generics Bulletin